Showing 26–30 of 30 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Tafaj S, Mokrousov I, Borroni E, Trovato A, Kapisyzi P, et al.
Albania is a Balkan country with moderate to low incidence of tuberculosis (TB) and very low prevalence of drug resistant TB. Here, we analyzed a country-wide multi-year Mycobacterium tuberculosis collection in order to detect possible dynamic trends of TB in Albania, with a focu…
World Health Organization
This web annex to the WHO consolidated guidance on tuberculosis data generation and use provides practical examples illustrating how tuberculosis (TB) diagnosis, treatment initiation and treatment outcomes should be recorded and reported within TB surveillance systems. Using a se…
Veronique R de Jager, MD, Prof. Rodney Dawson, MD, Prof. Andreas Diacon
This trial will evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of multiple oral doses of OPC-167832 in participants with uncomplicated, smear-positive, drug-susceptible pulmonary tuberculosis (TB).
Otsuka Pharmaceutical Development & Commercialization, Inc.
This trial will assess the safety and efficacy of OPC-167832 combined with delamanid and bedaquiline in participants with drug-susceptible tuberculosis (DS-TB) administered for 17 weeks compared to rifampin, isoniazid, ethambutol, pyrazinamide (RHEZ) administered for 26 weeks. E…
Markus Soner
Tuberculosis is a major yet preventable airborne infectious disease. From the infectious diseases caused by a single pathogen, tuberculosis has caused the most deaths in the world per year until the COVID-19 pandemic. In 2019, an estimated 10 million new TB cases emerged, and mor…